Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 60956-23-2 | MDL No. : | MFCD00079744 |
Formula : | C7H6Br2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LDCPXNOCWDGYIU-UHFFFAOYSA-N |
M.W : | 249.93 | Pubchem ID : | 34679 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 0.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 46.81 |
TPSA : | 0.0 Ų |
GI absorption : | Low |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.22 cm/s |
Log Po/w (iLOGP) : | 2.54 |
Log Po/w (XLOGP3) : | 3.67 |
Log Po/w (WLOGP) : | 3.52 |
Log Po/w (MLOGP) : | 4.1 |
Log Po/w (SILICOS-IT) : | 3.66 |
Consensus Log Po/w : | 3.5 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.2 |
Solubility : | 0.016 mg/ml ; 0.0000638 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -3.36 |
Solubility : | 0.109 mg/ml ; 0.000437 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.49 |
Solubility : | 0.00801 mg/ml ; 0.0000321 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 1.25 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | With nitric acid In water | Step A: 1,2-Dibromo-4-methyl-5-nitrobenzene 3,4-dibromotoluene (108.11 mL, 800 mmol) was added dropwise over 4 hours to nitric acid (90percent, 280 mL, 6000 mmol) that was cooled to 0° C. under a nitrogen atmosphere with 10 mechanical stirring. The internal temperature of the mixture was maintained below 10° C. during the addition and was stirred for 1 hour at 0° C. after completion of addition. Water (840 mL) was added drop-wise to the mixture maintaining the internal temperature below 10° C. The crude product was collected by filtration and was washed with water (5*500 mL) to remove the excess nitric acid. The solids were dried under high vacuum and purified by recrystallization from ethanol (800 mL) to produce 180.9 g (77percent yield) of the desired product as a solid. 1H NMR (400 mHz, CDCl3) δ 8.24 (s, 1H), 7.64 (s, 1H), 2.55 (s, 3H) |
77% | With nitric acid In water at 0 - 10℃; for 5 h; | Step A: 1,2-Dibromo-4-methyl-5-nitrobenzene 3,4-dibromotoluene (108.11 mL, 800 mmol) was added dropwise with mechanical stirring over 4 hours to nitric acid (90percent, 280 mL, 6000 mmol) that was cooled to 0° C. under a nitrogen atmosphere. The internal temperature of the mixture was maintained below 10° C. during the addition and the reaction mixture was stirred for 1 hour at 0° C. after completion of addition. Water (840 mL) was added drop-wise to the mixture while maintaining the internal temperature below 10° C. The crude product was collected by filtration and washed with water (5*500 mL) to remove the excess nitric acid. The solids were dried under high vacuum and purified by recrystallization from ethanol (800 mL) to provide 180.9 g (77percent yield) of the desired product as a solid. 1H NMR (400 MHz, CDCl3) δ 8.24 (s, 1H), 7.64 (s, 1H), 2.55 (s, 3H). |
77% | With nitric acid In water at 0 - 10℃; for 5 h; | Example 16; Preparation of (-SV5-(2,4-difluorophenoxy')-l -isobutyl-N-(2-oxopyrrolidin-3-yr)-lH- indazole-6-carboxamide (Ia); [00251] Step A: l,2-Dibromo-4-methyl-5-nitrobenzene: 3,4-dibromotoluene (108.11 mL, 800 mmol) was added dropwise- with mechanical stirring over 4 hours to nitric acid (90percent, 280 mL, 6000 mmol) that was cooled to 0 0C under a nitrogen atmosphere. The internal temperature of the mixture was maintained below 10 0C during the addition and the reaction mixture was stirred for 1 hour at 0 0C after completion of addition. Water (840 mL) was added drop- wise to the mixture while maintaining the internal temperature below 10 0C. The crude product was collected by filtration and washed with water (5 x 500 mL) to remove the excess nitric acid. The solids were dried under high vacuum and purified by recrystallizaton from ethanol (800 mL) to provide 180.9 g (77percent yield) of the desired product as a solid. 1H NMR (400 MHz5 CDCl3) δ 8.24 (s, IH), 7.64 (s, IH), 2.55 (s, 3H). |
[ 3278-88-4 ]
1,2,4-Tribromo-5-methylbenzene
Similarity: 0.93
[ 64382-93-0 ]
1,2-Dibromo-4-(bromomethyl)benzene
Similarity: 0.90
[ 3278-88-4 ]
1,2,4-Tribromo-5-methylbenzene
Similarity: 0.93
[ 64382-93-0 ]
1,2-Dibromo-4-(bromomethyl)benzene
Similarity: 0.90